Regulon

Regulon: R-950

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
141.4515610Pr-151Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
23198 ENSG00000068878 PSME4 Q14997
5351 ENSG00000083444 PLOD1 Q02809
11252 ENSG00000100266 PACSIN2 B0QYG7
23268 ENSG00000107554 DNMBP Q6XZF7
8795 ENSG00000120889 TNFRSF10B O14763
59269 ENSG00000127124 HIVEP3 Q5T1R4
58190 ENSG00000144579 CTDSP1 Q9GZU7
5784 ENSG00000152104 PTPN14 Q15678
824 ENSG00000162909 CAPN2 P17655
3673 ENSG00000164171 ITGA2 P17301
25836 ENSG00000164190 NIPBL Q6KC79
558 ENSG00000167601 AXL P30530
9792 ENSG00000179833 SERTAD2 Q14140
23654 ENSG00000196576 PLXNB2 O15031

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
BEMCENTINIBAXLSmall moleculeINHIBITORTyrosine-protein kinase receptor UFO inhibitor20
TIGATUZUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist30
GILTERITINIB FUMARATEAXLSmall moleculeINHIBITORTyrosine-protein kinase receptor FLT3 inhibitor40
GILTERITINIBAXLSmall moleculeINHIBITORTyrosine-protein kinase receptor UFO inhibitor40
CONATUMUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist20
BPI-9016AXLSmall moleculeINHIBITORTyrosine-protein kinase receptor UFO inhibitor10
DULANERMINTNFRSF10BProteinAGONISTTRAIL receptor-1 agonist20
VATELIZUMABITGA2AntibodyANTAGONISTIntegrin alpha-2 antagonist20
LEXATUMUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist10
DROZITUMABTNFRSF10BAntibodyAGONISTTumor necrosis factor receptor superfamily member 10B agonist20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-950

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs